WENDY JOHNSON: Open Payments
NPI 1457646812 · KILLEEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 36 payments from 6 companies in 2025. Trend: 2023 $511 · 2024 $593 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $255 |
| Otsuka America Pharmaceutical, Inc. | 9 | $197 |
| Alkermes, Inc. | 9 | $168 |
| Lundbeck LLC | 6 | $122 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: ABILIFY ASIMTUFII, INGREZZA, ARISTADA, SPRAVATO, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE.
Industry payments across TX — which companies pay providers there.
